Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
18.35
+0.69 (3.91%)
At close: Mar 9, 2026, 4:00 PM EDT
18.36
+0.01 (0.05%)
After-hours: Mar 9, 2026, 5:01 PM EDT
Definium Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,829 | 1,319 | 510 | 147 | 83 | 590 | |
| Market Cap Growth | 204.98% | 158.44% | 247.80% | 77.54% | -85.99% | -82.89% | |
| Enterprise Value | 1,386 | 1,151 | 239 | 43 | -72 | 444 | |
| Last Close Price | 17.66 | 13.39 | 6.96 | 3.66 | 2.20 | 20.70 | |
| PB Ratio | 5.25 | 3.97 | 2.11 | 1.88 | 0.55 | 3.89 | |
| P/TBV Ratio | 5.62 | 4.22 | 2.30 | 2.54 | 0.65 | 4.73 | |
| Debt / Equity Ratio | 0.12 | 0.12 | 0.09 | 0.18 | - | - | |
| Net Debt / Equity Ratio | -1.12 | -1.12 | -1.04 | -1.09 | -0.94 | -0.88 | |
| Net Debt / EBITDA Ratio | 2.23 | 2.23 | 2.42 | - | 2.14 | 1.43 | |
| Quick Ratio | 6.17 | 6.17 | 7.05 | 3.09 | 7.94 | 12.83 | |
| Current Ratio | 6.29 | 6.29 | 7.25 | 3.22 | 8.16 | 13.18 | |
| Return on Equity (ROE) | -64.06% | -64.06% | -68.01% | -83.59% | -37.54% | -81.78% | |
| Return on Assets (ROA) | -28.01% | -28.01% | -30.44% | -39.84% | -24.82% | -47.63% | |
| Return on Capital Employed (ROCE) | -44.50% | -44.50% | -39.50% | -101.70% | -43.60% | -60.90% | |
| Earnings Yield | -10.46% | -13.93% | -21.29% | -65.24% | -68.71% | -15.76% | |
| Buyback Yield / Dilution | -26.78% | -26.78% | -79.94% | -26.90% | -12.71% | -54.25% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.